Heidi Anne Duerr, MPH

BENNETT S CREEK PHARMACY

4208 FAIGLE RD

Articles

Study Provides Dosing Insight for Oxytocin in Preventing Obstetric Hemorrhage

April 30, 2012

Despite the widespread use of oxytocin as a prophylactic for obstetric hemorrhage, there is no clear recommendation as to the optimal dose. To provide insight into this issue, researchers conducted a double-masked randomized trial comparing two higher dose regimens with a standard dose regimen. Their results were published in a recent issue of Obstetrics & Gynecology.

Rectus Muscle Closure at Cesarean Is Associated With Fewer Adhesions

April 25, 2012

Methods used during closing after a cesarean section affect intra-abdominal adhesions, according to a new study published in American Journal of Obstetrics & Gynecology.

Laparoscopy for Adnexal Masses Is Safe and Effective During Pregnancy

April 23, 2012

Laparoscopy has been shown to be a safe and effective option for many diverse pelvic organ diseases, but how does the procedure fare during pregnancy? Due to the absence of large, comparative studies in pregnancy, there has been no definitive answer to this question. Now, researchers from Korea have found that laparoscopic surgeries can be safely used in women who are pregnant. Their results have been published in The Australian and New Zealand Journal of Obstetrics and Gynaecology.

HPV Vaccine Beneficial for Women with Previous Cervical and Vulvar Disease

April 20, 2012

Human papillomavirus vaccines provide still some benefit to women who have undergone treatment for HPV-related diseases, according to a new study published in the British Medical Journal.

After Breast Cancer, Omega-3s Fight Fatigue

April 16, 2012

Fatigue, which can plague patients’ years after cancer treatment has ended, may be the result of inflammation. Now, a new study published in the Journal of Clinical Oncology has found that omega-3 may help reduce fatigue associated with inflammation in these patients.

Betamethasone Dosing at 12 Hours is Beneficial in Preterm Birth

April 10, 2012

Research has shown that glucocorticoid administration has a significant beneficial effect for preterm births, as it decreases the incidence of respiratory distress syndrome in infants delivered between 24 weeks and 34 weeks gestation, reduces the incidence of intraventricular hemorrhage, improves circulatory stability in premature infants, reduces the need for oxygen and ventilatory support, and reduces overall neonatal mortality.